Event Details

ASCO Annual Meeting: Pilot Integrated Biomarker Study of VX15/2503 in Combination with Ipilimumab and/or Nivolumab in Patients with Resectable Metastatic Melanoma

06/03/19 at 2:15 PM EDT
Event Details
Title
ASCO Annual Meeting: Pilot Integrated Biomarker Study of VX15/2503 in Combination with Ipilimumab and/or Nivolumab in Patients with Resectable Metastatic Melanoma
Date / Time
06/03/19 at 2:15 PM EDT